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Antioxidant activityAbstract Objective: The present study was designed to investigate the in vitro anti-inflammatory,
antimicrobial, cytotoxic and antioxidant effects of Naproxen metal complexes.
Methodology: The anti-inflammatory activity was evaluated by HRBC membrane stabilization
method while antimicrobial activity by disk diffusion method. The cytotoxicity was evaluated by
brine shrimp lethality bioassay and compared with vincristine sulfate. Antioxidant potential was
evaluated in terms of DPPH radical scavenging potential, ABTS scavenging potential, reducing
power assay, superoxide dismutase assay and total antioxidant capacity by specific standard
procedures.
Results: The Naproxen metal chelates showed significant anti-inflammatory effects in dose depen-
dent manner. Naproxen standard showed maximum inhibition occurred 73.21% at the dose of
2000 lg/ml. Among Naproxen metal chelates, Naproxen silver complex showed potent antimicro-
bial activity against most of the tested microorganisms while Naproxen zinc complex showed better
activity against gram positive strains than gram negative. In brine shrimp lethality bioassay, varying
degree of lethality to Naproxen metal chelates was observed showing Naproxen iron complex sur-
prisingly very potent cytotoxic activity compared to vincristine sulfate where other metal complexes
displayed reduced cytotoxicity than parent Naproxen while Naproxen exhibited the lowest antiox-
idant assay among all the metal complexes compared to the standard ascorbic acid.
Conclusion: The present study demonstrated that Naproxen and its complexes possess in vitro
anti-inflammatory activity while silver, zinc and iron complexes possess higher antimicrobial and
cytotoxic properties than the parent ligand and possess very mild antioxidant activity.
 2016 Alexandria University Faculty of Medicine. Production and hosting by Elsevier B.V. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Recent findings on the chemical and biochemical activity of
metal complexes play an essential role in agriculture, pharma-
ceutical and industrial chemistry.1 In therapeutics, the use of
metal complexes with traditional drugs as therapeutic agents
for treatment of different diseases has been extensivelyd (2016),
2 M.S. Hasan, N. Dasstudied.2–6 As they generally possess different mechanisms of
activity from the organic compounds, the development of
metal complexes provides an alternative route of novel drug
delivery system.7 Very recent works on metal complexes have
proved that binding of a drug to metalloelement enhances its
activity and in many cases the complex possesses even such
activity that the parent compound does not have.8 Thus we
have motivated to study metal binding properties of Naproxen
derivatives with different transition metal ions and analyzed its
different biological properties for the sake of getting any new
possibilities of using Naproxen metal complexes for different
therapeutic purposes.
Our whole study was designed for understanding the most
potential therapeutic activities achieved by formation of metal
complexation in the most important biological fields such as
inflammation, cytotoxicity, antimicrobial efficacy or efficiency
and anti-oxidation reactions. We studied anti-inflammatory
activity as there are many modes of anti-inflammatory actions
of different transition metals when complexes with organic
ligands.9 Anti-inflammatory activity is measured in HRBC
or erythrocyte membrane which is analogous to the lysosomal
membrane and its stabilization implies that the synthetic com-
pound may stabilize lysosomal membranes.10 Stabilization of
human red blood cell membrane (HRBC) by hypotonicity
induced membrane lysis can be taken as an in vitro measure-
ment of anti-inflammatory activity of the drugs. Cytotoxic
properties are studied for the complexes which are considered
as valuable tool for the screening of anti-tumor or anti-
neoplastic agents under controlled in vitro conditions. We used
brine shrimp lethality bioassay for cytotoxic studies as a pre-
liminary screening technique to find out the potential toxicity
profiles.
Multi-Drug Resistant (MDR) microorganisms are the great
risk of health hazards in many countries for the today’s world.
There is no doubt that metal complexes are highly well known
for their anti-microbial activities for both resistant and non-
resistant species. It is also clearly observed from many studies
that anti-microbial activities of metal complexes sometimes
possess enhanced activity than their conventional organic
drugs itself because metal complexation may lead to varying
degree of synergistic effect for either metal ion or ligand or
for both.11–13 Thus, we used a vast range spectrum of microor-
ganisms for determining the anti-microbial properties of syn-
thesized compounds by disk diffusion method. Antioxidant
activities are related to those compounds which are capable
of protecting a biological system against the potential harmful
effects of oxidative processes, therefore, making it important in
medicine for the prevention and treatment of free radical
pathologies.9 It has received increased attention in the last
years from nutritionists and medical researchers due to their
potential chemical and molecular mechanisms in oxidative
stress, DNA damage, protein modification, and enzyme activ-
ity with emphasis on the chemical and cell-free biological sys-
tem.14–17
To the best of our knowledge and available literature on the
subject no detailed research works have been done on all of
these properties of Naproxen metal complexes. In the present
study we report Naproxen metal complexes with there
in vitro anti-inflammatory, cytotoxic, anti-microbial and
antioxidant properties.Please cite this article in press as: Hasan MS, Das N A detailed in vitro study of napro
http://dx.doi.org/10.1016/j.ajme.2016.06.0032. Material and methods
2.1. General procedure for synthesis of transition metal
complexes of Naproxen
Equimolar metal salts dissolved in water were added to the
sodium salt of Naproxen so that the ratios n(metal):n(ligand)
of monovalent, divalent and trivalent ions used were 1:1, 1:2
and 1:3 respectively in each case and immediate precipitation
was occurred. Then the solid complexes were isolated by filtra-
tion, washed with the corresponding solvent (water) and finally
dried at room temperature.18 The synthesized samples were
freely soluble in different coordination solvents such as
DMF, DMSO, THF and moderately soluble in chloroform,
CCl4. However, they were insoluble in water, ethanol, and
acetone.
2.2. Chemicals and reagents
All chemicals were obtained commercially and were of analyt-
ical grade. Sodium phosphate was collected from the Depart-
ment of Clinical Pharmacy and Pharmacology, Faculty of
Pharmacy, University of Dhaka, Bangladesh. All the solu-
tions, reagents and buffers were prepared with distilled water.
Vincristine sulfate, used as a standard drug in cytotoxicity
assay was collected from the Techno Drugs Limited,
Bangladesh. Dimethyl sulfoxide (DMSO) was purchased from
Sigma-Aldrich, India. Sodium Chloride Crystal GR from
Merck Ltd, Mumbai, India, was used to prepare seawater in
brine shrimp lethality bioassay. 1,1-Diphenyl-2-
picrylhydrazyl (DPPH), L-ascorbic acid, and gallic acid were
purchased from Sigma Chemical Co. (St. Louis, USA).
Naproxen was used as a standard drug.
2.3. In vitro anti inflammatory activity
2.3.1. Preparation of red blood cells
Human blood was collected from a donor not consuming any
NSAIDS drugs for past two weeks. The blood was subjected to
centrifugation and the supernatant part was carefully pipetted
out with sterile pipettes. The packed cells were resuspended
with equal volume of normal physiological saline (pH 7.4)
and centrifuged again. The process was repeated five times
until the supernatants were clear. A 10% HRBC suspension
was then prepared with normal physiological saline and used
immediately.19
2.3.2. Membrane stabilizing activity assay
4.5 ml of reaction mixture consisting of 2 ml hypotonic saline
(0.25% w/v NaCl), 1 ml of sodium phosphate buffer
(0.15 M, pH 7.4) and 1 ml of metal chelates was dissolved in
normal physiological saline. Then 0.5 ml of 10% HRBC was
also added. Two controls were used, one with 1.0 ml of iso-
tonic saline instead of metal chelates, and the second control
with 0.5 ml of isotonic saline instead of red blood cells. The
mixture was incubated at 56 C for 30 min. The tubes were
cooled under running water for 20 min and the mixture was
centrifuged at 3000 rpm. The supernatants were separated
and the absorbance of the supernatants was noted atxen metal complexes in quest of new therapeutic possibilities, Alex J Med (2016),
In vitro study of naproxen metal complexes 3560 nm. The percentage membrane stabilizing activity was
determined using the equation shown below.20 Naproxen was
used as standard.
%of Membrane stability ¼ 100 ðAbs: of drug sample
Abs: of drug controlÞ
 100=ðAbs: of blood controlÞ
Blood control represented 100% lysis or zero percent
stability.
2.4. Collection of microorganisms
The microbial species used in the present study were Bacillus
cereus, Bacillus subtilis, Sarcina lutea, Staphylococcus aureus,
Bacillus megaterium, Escherichia coli, Salmonella paratyphi,
Salmonella typhi, Shigella boydii, Shigella dysenteriae, Pseu-
domonas aeruginosa, Vibrio mimicus, Vibrio parahaemolyticus,
Candida albicans, Aspergillus niger and Saccharomyces cere-
visiae. These were collected as pure cultures from the Institute
of Nutrition and Food Sciences, Dhaka University, Dhaka,
Bangladesh.
2.5. Antimicrobial activity
A total of 16 reference microbial strains (five Gram-positive,
eight Gram-negative and three fungi) were used as the test
organism for the antimicrobial screening. The antimicrobial
activity of metal chelates against the test organisms was per-
formed by disk diffusion method using standard disk (5 lg/
disk) for comparison.21 Ciprofloxacin was used as the standard
disk for comparing antibacterial and miconazole for antifungal
activity. The test organisms were inoculated on 10 ml previ-
ously sterilized nutrient agar media, mixed thoroughly and
transferred immediately to the sterile Petri dish under an asep-
tic condition using a sterile loop. The paper disks containing
the samples and standard disk were placed to the correspond-
ing Petri dish and were incubated at concentration of
106 CFU/ml for overnight at 37 C. Clear zone of inhibition
around the disks represented the presence of antimicrobial
activity which was measured in millimeter (mm).
2.6. Determination of cytotoxicity
The cytotoxic potentiality of all Naproxen metal chelates was
performed on brine shrimp nauplii using Mayer’s method.22,23
The eggs of brine shrimp (Artemia salina Leach) were collected
from the Department of Clinical Pharmacy and Pharmacology,
University of Dhaka and hatched in a tank containing 1 l of
simulated seawater at a temperature around 37 C and pH 8.4
with constant oxygen supply. Two days were allowed to hatch
and mature the nauplii. About 4 mg of each sample was dis-
solved in DMSO and solutions with varying concentrations
(400, 200, 100, 50, 25, 12.5, 6.25, 3.125, 1.563, 0.781 lg/ml)
obtained by serial dilution technique. The prepared test solu-
tions were added to the pre-marked vials containing 10 live
brine shrimp nauplii in 5 ml simulated seawater and incubated
for 24 h. After incubation period, the vials were examined using
a magnifying glass in order to count the number of survived
nauplii in each vial. From this data, the lethality percent of
the brine shrimp nauplii was calculated for each concentration.Please cite this article in press as: Hasan MS, Das N A detailed in vitro study of napro
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was calculated from the plotted graph of percentage of the
shrimp mortality vs logarithm of the sample concentration,
which was defined as the amount of sample required to kill
50% of brine shrimps within 24 h of exposure respectively.
2.7. Antioxidant activity
2.7.1. DPPH free radical scavenging activity
The method of Kirubha24 was used for performing the DPPH
radical scavenging activity. Serial dilutions from the stock
solutions were carried out to obtain concentrations of 5, 10,
20, 40, 60, 80, 100, 250 and 500 lg/ml. An equal amount of
the sample solution and 0.1 mM of solution of DPPH were
mixed. The mixture was vortexed and allowed to stand in
the dark at 25 C for 30 min. After incubation, the absorbance
of the mixture was read against a blank at 517 nm using a dou-
ble beam Analykjena UV/Visible spectrophotometer (Model
205, Jena, Germany).
The radical scavenging activity was expressed as the inhibi-
tion percentage (I%) and calculated as per the following
equation:
I ð%Þ ¼ Ablank  Asample=Ablank
  100
where Ablank is the absorbance of the control (containing all
the reagents except the testing compound) and Asample is the
absorbance of the experimental sample with all reagents.
The IC50 value (the concentration of a sample required to
scavenge 50% DPPH radical) was calculated from the plot
of inhibition (%) against the concentration of the metal che-
lates. All determinations were carried out in triplicate and
the average was noted. Ascorbic acid was used as the standard
antioxidant.
2.7.2. ABTS radical scavenging activity
The antioxidant capacity of Naproxen and its derived com-
plexes was determined by ABTS radical cation as described
by Luo and coworkers25, with some modifications. The ABTS
radical cation was produced by reacting 7 mM ABTS solution
with 2.45 mM potassium persulfate and the mixture was
allowed to stand in the dark at room temperature for 16 h.
The ABTS solution was diluted with sample 01 to an
absorbance of 0.70 ± 0.02 at 734 nm. 1 ml of sample at
different concentrations 5, 10, 20, 40, 60, 80, 100, 250, and
500 lg/ml was added to 1 ml of the ABTS solution and mixed
vigorously. The reaction mixture was allowed to stand at room
temperature for 6 min before the absorbance at 734 nm was
recorded.
The ABTS scavenging effect was calculated as per the
following equation:
ABTS scavenging effect ¼ AoAs=Aoð Þ  100
where
Ao = absorbance of control.
As = absorbance of sample.
The IC50 value (the concentration of a sample required to
scavenge 50% ABTS radical) was calculated from the plot of
inhibition (%) against the concentration of the metal chelates.
All determinations were carried out in triplicate and the aver-xen metal complexes in quest of new therapeutic possibilities, Alex J Med (2016),
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antioxidant.
2.7.3. Reducing power assay
The reducing power of Naproxen and its derived complexes
was determined according to the method followed by Fathi
and co-workers.26 Different concentrations of Naproxen and
its derived complexes at 5, 10, 20, 40, 60, 80, 100, 250 and
500 lg/ml in 1 ml of distilled water were mixed with phosphate
buffer (2.5 ml, 0.2 M, pH 6.6) and potassium ferricyanide
[K3Fe(CN)6] (2.5 ml, 1%). The mixture was incubated at
50 C for 20 min. A 10% solution of trichloroacetic acid
(2.5 ml) was added to the mixture, which was then centrifuged
at 3000 rpm for 10 min. The upper layer of the solution
(2.5 ml) was mixed with distilled water (2.5 ml) and FeCl3
(0.5 ml, 0.1%) and the absorbance of the mixture was mea-
sured at 700 nm with spectrophotometer. Increased absor-
bance of the reaction mixture indicated increased reducing
power. All the tests were carried out in triplicate and average
of the absorptions was recorded. Ascorbic acid was used as
the standard reference compound.
2.7.4. Superoxide radical scavenging activity
The superoxide anion scavenging activity was measured as
described by Omwamba and coworkers.27 The superoxide
anion radicals were generated in 3.0 ml of Tris-HCl buffer
(16 mM, pH 8.0), containing 0.5 ml of nitro blue tetrazolium
(NBT) (0.3 mM), 0.5 ml reduced nicotinamide adenine dinu-
cleotide (NADH) (0.936 mM) solution, 1.0 ml Naproxen and
its derived complexes of different concentrations 5, 10, 20,
40, 60, 80, 100, 250 and 500 lg/ml and 0.5 ml Tris-HCl buffer
(16 mM, pH 8.0). The reaction was started by adding 0.5 ml
PMS solution (0.12 mM) to the mixture. The mixture was then
incubated at 25 C for 5 min before the absorbance was mea-
sured at 560 nm against a blank sample.
The percent inhibition was calculated by using the follow-
ing equation:
Superoxide radical scavenging activity¼ AoA1=Aoð Þ100f g
where
Ao is the absorbance of the control reaction.
A1 is the absorbance presence in Naproxen, its derived
complexes and reference.
The process was done in triplicate and the results were
averaged.
2.7.5. Total antioxidant capacity
The total antioxidant capacity of Naproxen and its derived
complexes was evaluated by the phosphomolybdenum assay
method28 which is based on the reduction of Mo (VI) to
Mo (V) and the subsequent formation of a green phosphate-
Mo (V) complex in acidic condition. The metal chelates were
allowed to mix with 3.0 ml of the reagent solution (0.6 M
H2SO4, 28 mM Na3PO4, 4 mM ammonium molybdate). The
reaction mixture was incubated at 95 C for 90 min. After
letting the solution cool back to room temperature, the
absorbance was measured at 695 nm using a UV-Visible
spectrophotometer against a blank solution. The antioxidantPlease cite this article in press as: Hasan MS, Das N A detailed in vitro study of napro
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ascorbic acid.
2.8. Statistical analysis
All results were expressed as mean ± SEM of three parallel
measurements. The differences between experimental groups
were compared by one way ANOVA followed by Student’s
t-test and were considered statistically significant when
P< 0.001. Regression analysis was carried out for analyzing
the data obtained from brine shrimp lethality bioassay.
3. Results
3.1. Characterization of metal complexes of Naproxen
Physical, analytical and thermal properties, NMR spectra,
FTIR spectra, scanning electron microscopy and HPLC study
of Naproxen metal complexes were described by Hasan.18
3.2. In vitro membrane stability activity
The results of in vitro membrane stability activity of Naproxen
metal complexes are shown in Table 1. The metal chelates
showed significant anti-inflammatory activity in a concentra-
tion dependent manner. Incubation of the erythrocyte suspen-
sion with different concentrations of naproxen metal chelates
gave significant anti-inflammatory properties. Naproxen stan-
dard showed 68.75% of membrane protection at the concen-
tration of 100 lg/ml and maximum inhibition occurred
73.21% at the dose of 2000 lg/ml. On the other hand, among
Naproxen metal chelates, Cobalt-Naproxen complex showed
highest protection of RBC membrane stabilization i.e.
71.43%, 82.14% and 85.71% in the concentration of 100 lg/
ml, 1000 lg/ml and 2000 lg/ml respectively. Almost same
anti-inflammatory activity was shown by Iron-Naproxen com-
plex where Zinc-Naproxen complex showed RBC membrane
stability up to 76.79%.
3.3. Antimicrobial activity
The results of different metal chelates of Naproxen with disk
diffusion method are shown in Table 2. The antimicrobial
activity of all test metal chelates was tested using concentration
400 lg/disk. Naproxen cobalt and silver complexes showed
considerable antimicrobial activity on various microorgan-
isms. Other test samples did not possess any antimicrobial
activity against any of the microorganisms.
3.4. Cytotoxic activity
In brine shrimp lethality bioassay, percentage of mortality
increased gradually with the increase in concentration of the
test samples. The lethal concentration (LC50) of the test sam-
ples after 24 h was obtained by a plot of percentage of the
shrimps died against the logarithm of the sample concentration
(toxicant concentration) and the best-fit line was obtained
from the curve data by means of regression analysis.
Vincristine Sulfate (VS) was used as positive control and the
LC50 for VS was found as 0.544 lg/ml. Compared with thexen metal complexes in quest of new therapeutic possibilities, Alex J Med (2016),
Table 1 Results of in vitro anti-inflammatory activity of Naproxen metal complexes.
Group Concentration Absorbance (560 nm) % protection of HRBC membrane
Control – 0.112 ± 0.001 –
Standard (Naproxen) 100 lg/ml 0.093 ± 0.001a 68.75
1000 lg/ml 0.092 ± 0.0003a 69.64
2000 lg/ml 0.088 ± 0.001a 73.21
Copper-Naproxen complex 100 lg/ml 0.165 ± 0.002a 4.46
1000 lg/ml 0.178 ± 0.001a 7.14
2000 lg/ml 0.216 ± 0.001a 41.07
Cobalt-Naproxen complex 100 lg/ml 0.090 ± 0.001a 71.43
1000 lg/ml 0.078 ± 0.001a 82.14
2000 lg/ml 0.074 ± 0.0008a 85.71
Iron-Naproxen complex 100 lg/ml 0.082 ± 0.001a 78.57
1000 lg/ml 0.080 ± 0.0008a 80.36
2000 lg/ml 0.075 ± 0.0003a 84.82
Silver-Naproxen complex 100 lg/ml 0.109 ± 0.001 54.46
1000 lg/ml 0.114 ± 0.0006 50.00
2000 lg/ml 0.139 ± 0.001a 27.68
Zinc-Naproxen complex 100 lg/ml 0.091 ± 0.0005a 70.54
1000 lg/ml 0.086 ± 0.0008a 75.00
2000 lg/ml 0.084 ± 0.001a 76.79
Results were expressed as mean ± SEM for n= 3 observations.
a P< 0.001 was considered significant compared with control.
Table 2 Antimicrobial activity of Naproxen and metal complexes.
Test microorganisms Zone of inhibition (in mm by transparent scale)
Ciprofloxacin Naproxen N-Cu N-Co N-Fe N-Ag N-Zn
Gram positive bacteria
Bacillus cereus 32 – 14 13 5 18 21
Bacillus megaterium 31 – 12 15 3 16 18
Bacillus subtilis 30 – 17 15 7 21 17
Staphylococcus aureus 28 – 6 10 8 19 12
Sarcina lutea 31 – – – 9 17 15
Fungi (Miconazole as standard)
Candida albicans 28 – 10 9 – 15 13
Aspergillus niger 24 – 7 – – 13 16
Aspergillus flavus 25 – 9 – 8 16 18
Saccharomyces cerevisiae 22 – 12 7 6 19 10
Gram negative bacteria
Escherichia coli 37 – 11 17 24 20 8
Pseudomonas aeruginosa 33 – 9 14 13 17 7
Salmonella paratyphi 28 – – 15 16 14 10
Salmonella typhi 26 – – – 12 9 4
Shigella boydii 29 – 13 – – 11 6
Shigella dysenteriae 27 – 14 – – 13 9
Vibrio mimicus 30 – 3 5 6 7 3
In vitro study of naproxen metal complexes 5negative control, VS (positive control) gave significant
mortality.
In brine shrimp lethality bioassay, varying degree of lethal-
ity to Naproxen metal chelates was observed with exposure to
different dose levels of the test samples (Tables 3 and 4). Cop-
per, cobalt, silver and zinc complexes showed reduced cytotox-
icity compared to parent Naproxen whereas Naproxen iron
complex with the LC50 value of 0.205 lg/ml displayed greater
activity compared to the Vincristine Sulfate (LC50 valuePlease cite this article in press as: Hasan MS, Das N A detailed in vitro study of napro
http://dx.doi.org/10.1016/j.ajme.2016.06.0030.544 lg/ml). Naproxen iron complex showed very potent
cytotoxic activity than standard and thus further other ways
of cytotoxicity study would be performed in future.
3.5. DPPH free radical scavenging activity
The percentage of DPPH neutralization of Naproxen metal
and its complexes were found to be concentration dependent.
Naproxen Iron complex produced the maximum free radicalxen metal complexes in quest of new therapeutic possibilities, Alex J Med (2016),
Table 3 Percent of mortality of the nauplii of Naproxen metal complexes.
Sl. no. Concentration (C) (lg/ml) Mortality (%)
Naproxen N-Cu N-Co N-Fe N-Ag N-Zn
1 400 100 20 20 100 20 20
2 200 100 10 20 100 10 10
3 100 100 10 10 100 10 10
4 50 100 0 0 100 10 0
5 25 100 0 0 100 0 0
6 12.5 60 0 0 100 0 0
7 6.25 50 0 0 100 0 0
8 3.125 20 0 0 70 0 0
9 1.5625 0 0 0 50 0 0
10 0.78125 0 0 0 50 0 0
Figure 1 DPPH scavenging activity of Naproxen metal and its
complex. N-Co: Naproxen Cobalt complex, N-Fe: Naproxen
Iron complex, N-Zn: Naproxen Zinc complex, N-Ag: Naproxen
Silver complex, N-Cu: Naproxen Copper complex.
Figure 2 ABTS scavenging activity of Naproxen metal and its
complex.
Table 4 LC50 values of the test samples of Naproxen metal
chelates.
Test sample Regression line R2 LC50 (lg/ml)
VS y= 33.22x+ 58.78 0.958 0.544
Naproxen y= 44.091x+ 7.9996 0.864 8.96
N-Cu y= 46.399x  3.5343 0.619 14.25
N-Co y= 47.449x  4.2923 0.638 13.94
N-Fe y= 19.126x+ 63.141 0.649 0.205
N-Ag y= 46.643x  3.2877 0.733 13.88
N-Zn y= 46.039x  3.5343 0.619 14.55
6 M.S. Hasan, N. Dasscavenging activity and Naproxen was found to produce weak-
est free radical scavenging activity while compared to that of
reference antioxidant of the test. Fig. 1 represents the
percentage of DPPH neutralization activity of all complexes
considered in the study.
3.6. ABTS radicals scavenging activity
The percentage of ABTS neutralization of Naproxen metal
and its derived complex were found to be concentration
dependent. Naproxen Iron complex produced the maximum
free radical while Naproxen metal produced weakest free
radical scavenging activity. Fig. 2 represents the percentage
of ABTS neutralization activity of all complexes considered
in the study.
3.7. Reducing power assay
The reducing power was also found to be concentration depen-
dent. Here, Naproxen Copper complex provided the most
intense reducing power with value of 0.33 ± 0.005 at 500 lg/
ml concentration, and Naproxen metal produced the least
reducing power assay. Fig. 3 represents the reducing power
assay of all complexes in the study.
3.8. Superoxide dismutase radical scavenging activity
The superoxide dismutase radical scavenging activity of
Naproxen metal and its complex were found to be
concentration dependent. Like percentage of DPPH neutral-Please cite this article in press as: Hasan MS, Das N A detailed in vitro study of napro
http://dx.doi.org/10.1016/j.ajme.2016.06.003ization activity, Naproxen iron complex provided most super-
oxide scavenging activity with the value of 53.21 ± 0.19 lg/ml
concentration and Naproxen metal produced least superoxide
scavenging activity. Fig. 4 represents the reducing power assay
of all complexes in the study.xen metal complexes in quest of new therapeutic possibilities, Alex J Med (2016),
Figure 3 Reducing potential of Naproxen metal and its
complex.
Figure 4 Superoxide potential of Naproxen metal and its
complex.
In vitro study of naproxen metal complexes 73.9. Total antioxidant capacity
Total antioxidant capacity of all complexes is expressed in
Table 5. The most powerful antioxidant activity was recorded
in Naproxen iron complex which amounted to 1.54
± 0.04 mg AAE equivalents/g of dry weight while Naproxen
metal was found to provide the least antioxidant activity which
amounted to 0.81 ± 0.01 mg AAE equivalents/g of dry
weight.Table 5 Total antioxidant capacity of Naproxen metal and its
derived complexes.
Name of
sample
Absorbance for 500 ppm
at 695 nm
Total antioxidant
capacity (AAE/g)
Naproxen 0.554 ± 0.001 0.81 ± 0.01
N-Cu 0.0823 ± 0.004 1.37 ± 0.03
N-Co 0.0846 ± 0.005 1.38 ± 0.02
N-Fe 0.0921 ± 0.018 1.54 ± 0.04
N-Zn 0.0774 ± 0.032 1.29 ± 0.01
N-Ag 0.0667 ± 0.017 1.19 ± 0.05
Values are expressed as mean ± SD (n= 3).
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Almost all Naproxen metal complexes showed prominent anti-
inflammatory activity. However, in case of Naproxen Copper
complex and Naproxen Silver complex, there was a decrease
in stability of RBC membrane. It was due to the fact that Cop-
per and Silver made complex with the released hemoglobin
thus altering the absorbance value. The reaction of hemoglo-
bin (Hb) with copper (II) complex was studied in phosphate
buffer by ultraviolet-visible spectrophotometry.29 The result
showed that the interaction of Hb and Cu(II) complex pro-
duced complex with its maximum absorption peak at
537 nm. At the maximum absorption, the composition of the
complex was determined to be n(Hb):n(Cu(II)) = 1:4. A pre-
liminary investigation elucidated the reaction mechanism that
the Hb and Cu(II) complex was combined mainly by electro-
static attraction.
As the present study also carried out at 560 nm, it was pre-
dicted that Cu(II) ions present in the Naproxen copper com-
plex were combined by electrostatic attraction with
hemoglobin thus providing significantly higher absorbance
than any other samples.
The interaction as well as the formation of a bioconjugate
of human hemoglobin (Hb) with silver (Ag) was also reported
recently. The UV-Vis study demonstrated the perturbation of
the heme band and generated conformational heterogeneity
within the heme group in the presence of silver FTIR spectra
indicated alpha-helix to beta-sheet conversion, and unfolding
of Hb was also responsible for the bioconjugate formation.30
The overall data showed that there was a change in the sec-
ondary as well as the tertiary structure of Hb after conjugation
with silver. For these reasons, Naproxen copper and silver
complex showed no feasible anti-inflammatory activity
in vitro test.
Naproxen silver complex showed potent antimicrobial
activity against most of the tested microorganisms compared
to other complexes. Naproxen zinc complex showed better
activity against gram positive strains than gram negative.
Naproxen iron complex showed potent antimicrobial activity
against gram negative E. coli than other strains. Naproxen
copper and cobalt complexes had variable moderate activity
against few microorganisms. According to Hard–soft acid base
theory (HSAB theory) soft acids such as Ag(I) and borderline
acids (such as Co(II), Cu(II) and Zn(II)) tend to associate
tightly with soft bases, such as the sulhydryl (R-SH) groups
that are found in proteins. Consequently, the antibacterial tox-
icity of these metals is approximately proportional to their
affinity for S atom.31–33
Naproxen iron complex showed surprisingly very potent
cytotoxic activity compared to vincristine sulfate while other
metal complexes displayed reduced cytotoxicity than parent
Naproxen. Antimicrobial and cytotoxic activity of iron
obtained here demonstrated that iron had inhibitory effects
on bacterial and cellular growth. These findings in agreement
with results obtained from other studies of electron micro-
scopy suggested that the integrity of the cytoplasmic mem-
brane was severely compromised by exposure to toxic doses
of iron.34,35 Based on these results we predicted that there
might be any antioxidant activity of these compounds; how-
ever, there was nothing at all.xen metal complexes in quest of new therapeutic possibilities, Alex J Med (2016),
8 M.S. Hasan, N. DasAs Naproxen exhibited the lowest antioxidant property, the
metal complexes had better antioxidant activity than
Naproxen, however, still lower compared to the standard
ascorbic acid. As a result, this study provides evidence that
the chelation of different metal complexes with Naproxen
had significant influence on the antioxidant activities in differ-
ent in vitromodel systems. Similar activity was also observed in
other works related to transition metal complexes where signif-
icant antioxidant activity was found. This was due to the reac-
tion capability of the metal complexes with the free radicals or
ions present in the system. In was observed that almost all metal
complexes showed the same plateau and the inhibition level of
DPPH, ABTS and superoxides was around 40%. As we men-
tioned before that the metal complexes had better antioxidant
activity than Naproxen, we assumed that the antioxidant activ-
ity solely came from the metal portion of the complexes.
Naproxen structure might not participate in such activity. Fur-
thermore, their antioxidant activity was almost same indicating
that there was no any significant difference in mechanism of
antioxidant activity because all metals were surrounded by
the same ligand making a similar coordination sphere. The
extent of inhibition activity was similar to all metals probably
due to the same level of reaction with the free radicals or ions
regardless of different metal complexes and coordination num-
bers. Moreover, in vitro anti-oxidation methods are not suitable
for determining anti-oxidant properties of Naproxen metal
complexes as the samples were too much difficult to dissolve.
This is why our results might not be the proper indication for
the anti-oxidant properties of these metal complexes. We would
strongly suggest to perform in vivo experiment for antioxidant
activity determination for Naproxen metal complexes. Hence
further works on in vivo antioxidant activity can be done using
different transition metals in search of new metal complexes
with potent antioxidant activity in future.
5. Conclusion
From these investigations, it may be concluded that Naproxen
metal chelates showed significant in vitro anti-inflammatory
activity while Naproxen cobalt and silver complexes showed
moderate antimicrobial activity against some tested microor-
ganisms and Naproxen iron complex showed potent antitumor
activity compared to standard but displayed no antioxidant
properties. Therefore, for these compounds in vivo tests should
be performed to study the anti-inflammatory activity of these
samples as well as further research is essential to find out the
possible side effects that may provide because of central metal
of chelation and its principles responsible for such activity.
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